HomeTARO • NYSE
add
Taro Pharmaceutical Industries Ltd
Previous close
$42.24
Day range
$42.14 - $42.36
Year range
$24.22 - $45.76
Market cap
1.59B USD
Avg Volume
35.64K
P/E ratio
34.70
Dividend yield
-
Primary exchange
NYSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 157.14M | 12.89% |
Operating expense | 63.10M | 0.53% |
Net income | 20.21M | 178.16% |
Net profit margin | 12.86 | 146.36% |
Earnings per share | 0.56 | 194.74% |
EBITDA | 24.18M | 181.00% |
Effective tax rate | 39.40% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 902.22M | 4.44% |
Total assets | 2.16B | 2.16% |
Total liabilities | 384.09M | -3.40% |
Total equity | 1.78B | — |
Shares outstanding | 37.58M | — |
Price to book | 0.89 | — |
Return on assets | 1.96% | — |
Return on capital | 2.38% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 20.21M | 178.16% |
Cash from operations | 30.92M | 142.23% |
Cash from investing | 81.67M | 184.91% |
Cash from financing | — | — |
Net change in cash | 113.40M | 236.27% |
Free cash flow | -13.71M | -43.67% |
About
Taro Pharmaceutical Industries is an Israeli research-based pharmaceutical manufacturer publicly listed in the New York Stock Exchange. The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. The company's products are mainly sold in the United States, Canada and Israel. Taro Pharmaceutical Industries is reported to be on steady growth since 2008. Wikipedia
CEO
Founded
1959
Headquarters
Website
Employees
1,554
